| |
| |
|
| Insider
Information: |
Gillis Steven |
| Relationship: |
|
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
111,799 |
|
|
Indirect Shares
|
69,845,167 |
|
|
| Direct
Value |
$72,374 |
|
|
|
Indirect Value
|
$313,405,756 |
|
|
| Total
Shares |
69,956,966 |
|
|
| Total
Value |
$313,478,130 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -13.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trubion Pharmaceuticals, Inc |
TRBN |
Ex. Chair. & President... |
2006-10-18 |
0 |
2010-10-28 |
0 |
Premium* |
|
|
Bluebird Bio, Inc. |
BLUE |
Director |
2015-07-28 |
18,633 |
2015-07-28 |
90,675 |
Premium* |
|
|
VBI Vaccines Inc |
VBIV |
Director |
2019-09-19 |
84,416 |
2019-09-19 |
13,026,057 |
Premium* |
|
|
Q32 Bio Inc |
QTTB |
Director |
2018-04-02 |
0 |
2018-04-02 |
6,068,695 |
Premium* |
|
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
10% Owner |
2019-02-22 |
0 |
2019-02-22 |
1,865,800 |
Premium* |
|
|
Codiak Biosciences, Inc. |
CDAK |
Director |
2023-02-16 |
8,750 |
2022-09-13 |
7,503,903 |
Premium* |
|
|
Sana Biotechnology, Inc. |
SANA |
10% Owner |
|
0 |
2024-02-08 |
22,747,272 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
10% Owner |
2021-06-21 |
0 |
2021-06-21 |
1,254,405 |
Premium* |
|
|
Da32 Life Science Tech Acquisiti... |
DALS |
10% Owner |
2023-07-28 |
0 |
2023-07-28 |
650,000 |
Premium* |
|
|
Prime Medicine, Inc. |
PRME |
10% Owner |
2022-10-24 |
0 |
2024-02-15 |
15,456,594 |
Premium* |
|
|
Boundless Bio, Inc. |
BOLD |
|
|
0 |
2024-04-02 |
1,181,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2013-06-24 |
4 |
A |
$0.00 |
$0 |
I/I |
1,793,588 |
1,793,588 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-01-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(175,000) |
1,618,588 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
437 |
437 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
785 |
1,222 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-09-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(313,877) |
1,304,711 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-09-30 |
4 |
S |
$36.08 |
$1,157,988 |
I/I |
(32,095) |
1,272,616 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-10-01 |
4 |
S |
$34.75 |
$400,181 |
I/I |
(11,516) |
1,261,100 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-10-02 |
4 |
S |
$34.87 |
$1,658,208 |
I/I |
(47,554) |
1,213,546 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-10-03 |
4 |
S |
$35.74 |
$951,935 |
I/I |
(26,635) |
1,186,911 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-10-06 |
4 |
S |
$35.16 |
$847,356 |
I/I |
(24,100) |
1,162,811 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-10-07 |
4 |
S |
$35.15 |
$235,505 |
I/I |
(6,700) |
1,156,111 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2014-10-09 |
4 |
S |
$35.25 |
$4,053,888 |
I/I |
(115,000) |
1,041,111 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2015-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
448 |
1,670 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2015-01-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(179,360) |
861,751 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2015-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
11,837 |
13,507 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2015-06-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(538,076) |
323,675 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,126 |
18,633 |
0 |
- |
|
| BLUE |
Bluebird Bio, Inc. |
Director |
– • – |
2015-07-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(233,000) |
90,675 |
0 |
- |
|
| BOLD |
Boundless Bio, Inc. |
|
– – • |
2024-03-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
68,374 |
|
- |
|
| BOLD |
Boundless Bio, Inc. |
|
– – • |
2024-04-02 |
4 |
B |
$16.00 |
$3,200,000 |
I/I |
200,000 |
1,181,766 |
0.01 |
% |
|
| BOLD |
Boundless Bio, Inc. |
|
– – • |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
2,425,721 |
1,048,433 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Director |
– • – |
2020-10-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
63,963 |
|
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Director |
– • – |
2020-10-16 |
4 |
B |
$15.00 |
$3,525,000 |
I/I |
235,000 |
2,503,903 |
2.1 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Director |
– • – |
2020-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,204,940 |
2,268,903 |
0 |
- |
|
| CDAK |
Codiak Biosciences, Inc. |
Director |
– • – |
2022-09-13 |
4 |
B |
$0.00 |
$0 |
I/I |
5,000,000 |
7,503,903 |
2.02 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
